The balance sheet remains a fortress with zero total debt and a current ratio of 7.7, while retained earnings have grown to $2.8B, though cash has declined from $500.4M to $113.5M over the past year.
Cal-Maine Foods, Inc. (CALM) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | May'26 | May'25 | May'24 | May'23 | May'22 | May'21 | May'20 | May'19 | May'18 | May'17 | May'16 | May'15 | May'14 | May'13 | May'12 | May'11 | May'10 | May'09 | May'08 | May'07 | May'06 | May'05 | May'04 | May'03 | May'02 | May'01 | May'00 | May'99 | May'98 | May'97 |
|---|
| Total Current Assets | 1.58B | 1.97B | 1.24B | 1.12B | 661.52M | 519.93M | 522.25M | 567.75M | 587.52M | 436.21M | 626.28M | 508.96M | 445.39M | 414.88M | 442.2M | 355.04M | 338.16M | 241.69M | 224.26M | 156.31M | 125.68M | 125.96M | 151.94M | 85.18M | 75.31M | 76.84M | 70.33M | 89.9M | 97.3M | 81.5M |
| Cash & Short-Term Investments | 930.36M | 1.39B | 812.38M | 647.91M | 174.51M | 169.51M | 232.29M | 319.43M | 331.02M | 156.03M | 389.55M | 258.63M | 209.26M | 182.89M | 260.75M | 176.43M | 199.06M | 82.05M | 94.86M | 54.53M | 38.3M | 55.6M | 72.98M | 6.09M | 4.88M | 13.13M | 6.54M | 36.2M | 41.1M | 23.7M |
| Cash Only | 113.52M | 500.39M | 237.88M | 292.82M | 59.08M | 57.35M | 78.13M | 69.25M | 48.43M | 17.56M | 29.05M | 8.67M | 14.52M | 24.98M | 97.13M | 57.68M | 99.45M | 66.88M | 94.86M | 15.03M | 13.29M | 20.22M | 36.63M | 6.09M | 4.88M | 13.13M | 6.54M | 36.2M | 41.1M | 23.7M |
| Short-Term Investments | 816.84M | 892.71M | 574.5M | 355.09M | 115.43M | 112.16M | 154.16M | 250.18M | 282.59M | 138.46M | 360.5M | 249.96M | 194.74M | 157.9M | 163.62M | 118.75M | 99.6M | 15.16M | 0 | 39.5M | 25M | 35.38M | 36.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 264.43M | 272.36M | 162.44M | 187.21M | 219.4M | 126.64M | 98.38M | 71.76M | 85.84M | 117.2M | 79.28M | 101.98M | 87.52M | 82.59M | 62.77M | 67.34M | 43.59M | 44.63M | 47.93M | 38.18M | 26.13M | 16.74M | 22.36M | 19.49M | 17.38M | 16.02M | 14.57M | 14.6M | 13.7M | 13.1M |
| Days Sales Outstanding | 33.15 | 23.33 | 25.49 | 21.72 | 45.06 | 34.27 | 26.57 | 19.24 | 20.85 | 39.81 | 15.16 | 23.62 | 22.17 | 23.4 | 20.58 | 26.09 | 17.48 | 17.54 | 19.1 | 23.3 | 19.97 | 16.28 | 14.26 | 18.36 | 19.45 | 16.31 | 18.53 | 18.5 | 16.18 | 16.35 |
| Inventory | 375.26M | 295.67M | 261.78M | 284.42M | 263.32M | 218.38M | 187.22M | 172.24M | 168.64M | 160.69M | 154.8M | 146.26M | 146.12M | 147.99M | 117.16M | 110.02M | 93.97M | 97.53M | 76.77M | 62.21M | 57.84M | 45.63M | 49.9M | 51.01M | 46.11M | 47.12M | 43.91M | 38.4M | 41.4M | 42.6M |
| Days Inventory Outstanding | 61.16 | 44.76 | 53.53 | 53.24 | 66.74 | 67.07 | 58.3 | 55.23 | 53.91 | 57 | 44.82 | 45.23 | 46.86 | 50.32 | 46.92 | 53.04 | 47.94 | 49.17 | 45.38 | 47.35 | 50.83 | 49.01 | 45.91 | 59.07 | 57.68 | 57.44 | 63.32 | 60.99 | 59.82 | 68.89 |
| Other Current Assets | 11.49M | 6.98M | 5.24M | 5.38M | 4.29M | 5.41M | 4.37M | 4.33M | 2.02M | 2.29M | 0 | 153K | 1.36M | 70K | 140K | 186K | 1.55M | 0 | 0 | 1.39M | 3.41M | 6.68M | 5.01M | 6.86M | 6.03M | 0 | 5.31M | 700K | 1.1M | 2.1M |
| Total Non-Current Assets | 1.55B | 1.13B | 957.1M | 838.8M | 775.79M | 722.16M | 693.71M | 588.52M | 562.93M | 596.89M | 485.48M | 419.69M | 366.27M | 330.75M | 284.11M | 285.8M | 293.12M | 341.16M | 276.97M | 208.26M | 191.44M | 143.58M | 149.62M | 150.21M | 154.35M | 157.91M | 161.57M | 123.8M | 105.9M | 100.8M |
| Property, Plant & Equipment | 1.32B | 1.03B | 857.23M | 744.54M | 679.17M | 591.67M | 560.58M | 456.29M | 425.38M | 458.18M | 392.27M | 358.79M | 314.94M | 266.01M | 222.62M | 224.89M | 240.78M | 252.43M | 206.49M | 193.59M | 176.28M | 127.39M | 132.06M | 138.19M | 142.22M | 144.65M | 148.14M | 109.9M | 99.4M | 95.3M |
| Fixed Asset Turnover | 2.21x | 4.15x | 2.71x | 4.23x | 2.62x | 2.28x | 2.41x | 2.98x | 3.53x | 2.35x | 4.87x | 4.39x | 4.58x | 4.84x | 5.00x | 4.19x | 3.78x | 3.68x | 4.44x | 3.09x | 2.71x | 2.95x | 4.33x | 2.80x | 2.29x | 2.48x | 1.94x | 2.62x | 3.11x | 3.07x |
| Goodwill | 97.06M | 46.78M | 45.78M | 44.01M | 44.01M | 35.52M | 35.52M | 35.52M | 35.52M | 35.52M | 29.2M | 29.2M | 29.2M | 24.42M | 22.12M | 22.12M | 22.12M | 22.45M | 13.45M | 4.2M | 4.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 73.13M | 15.16M | 16M | 15.9M | 18.13M | 20.34M | 22.82M | 23.76M | 26.31M | 29.15M | 4.96M | 7.56M | 10.42M | 12.33M | 8.03M | 10.06M | 12.52M | 15.06M | 0 | 0 | 0 | 3.15M | 3.15M | 3.15M | 3.15M | 3.15M | 3.39M | 4.3M | 0 | 0 |
| Long-Term Investments | 5.6M | 11.1M | 11.2M | 16.53M | 19.28M | 59.06M | 63.73M | 70.95M | 66.81M | 69.3M | 53.98M | 18.84M | 6.79M | 20.41M | 22.33M | 19.14M | 17.71M | 51.22M | 54.17M | 7.91M | 8.32M | 0 | 0 | 0 | -7.7M | -7.5M | -4.6M | -10.3M | 0 | 0 |
| Other Non-Current Assets | 31.9M | 16.8M | 12.72M | 8.63M | 5.38M | 2.65M | 1.79M | 1.99M | 8.9M | 4.73M | 5.08M | 5.3M | 4.93M | 7.58M | 9.02M | 9.59M | 0 | 0 | 2.85M | 2.56M | 2.83M | 13.04M | 14.41M | 8.87M | 8.98M | 10.12M | 10.04M | 9.6M | -3.8M | 5.5M |
| Total Assets | 3.13B | 3.1B | 2.2B | 1.96B | 1.44B | 1.24B | 1.22B | 1.16B | 1.15B | 1.03B | 1.11B | 928.65M | 811.66M | 745.63M | 726.32M | 640.84M | 631.28M | 582.85M | 501.24M | 364.57M | 317.12M | 269.53M | 301.56M | 235.39M | 229.65M | 234.75M | 231.9M | 213.7M | 203.2M | 182.3M |
| Asset Turnover | 0.93x | 1.37x | 1.06x | 1.60x | 1.24x | 1.09x | 1.11x | 1.18x | 1.31x | 1.04x | 1.72x | 1.70x | 1.78x | 1.73x | 1.53x | 1.47x | 1.44x | 1.59x | 1.83x | 1.64x | 1.51x | 1.39x | 1.90x | 1.65x | 1.42x | 1.53x | 1.24x | 1.35x | 1.52x | 1.60x |
| Asset Growth % | 0.85% | 41.09% | 11.98% | 36.63% | 15.72% | 2.15% | 5.16% | 0.51% | 11.36% | -7.08% | 19.72% | 14.41% | 8.86% | 2.66% | 13.34% | 1.51% | 8.31% | 16.28% | 37.49% | 14.96% | 17.65% | -10.62% | 28.11% | 2.5% | -2.17% | 1.23% | 8.52% | 5.17% | 11.46% | 21.53% |
| Total Current Liabilities | 205.52M | 308.37M | 227.74M | 182.73M | 184.67M | 90.1M | 93.18M | 74.91M | 107.84M | 64.68M | 83.45M | 101.55M | 121.1M | 130.19M | 140.66M | 107.48M | 117.97M | 103.69M | 102.72M | 75.76M | 64.88M | 52.37M | 58.99M | 57.43M | 58M | 48.45M | 51.84M | 41.4M | 40.7M | 36.2M |
| Accounts Payable | 96.11M | 101.03M | 75.86M | 82.59M | 82.05M | 52.78M | 55.9M | 39.21M | 37.84M | 30.63M | 36.26M | 44.71M | 38.97M | 47.23M | 55.23M | 50.12M | 37.48M | 40.33M | 35.69M | 27.98M | 24.19M | 20.03M | 39.36M | 21.39M | 18.47M | 18.95M | 25.95M | 16.6M | 25.8M | 15.3M |
| Days Payables Outstanding | 15.66 | 15.3 | 15.51 | 15.46 | 20.8 | 16.21 | 17.41 | 12.57 | 12.1 | 10.86 | 10.5 | 13.82 | 12.5 | 16.06 | 22.12 | 24.17 | 19.12 | 20.33 | 21.1 | 21.3 | 21.26 | 21.52 | 36.22 | 24.77 | 23.1 | 23.1 | 37.42 | 26.37 | 37.28 | 24.74 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 696K | 906K | 1M | 1.7M | 3.54M | 4.83M | 16.32M | 10.06M | 10.22M | 10.37M | 11.46M | 11.74M | 29.97M | 22.21M | 21.83M | 18.88M | 11.9M | 10.15M | 9.6M | 12.59M | 17.36M | 7.18M | 14.61M | 4.1M | 4.5M | 4.5M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.33M | -7.18M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 61.04M | 147.07M | 75.56M | 53.12M | 50.18M | 12.6M | 13M | 11.09M | 30.05M | 13.41M | 0 | 0 | 30.45M | 20M | 25.47M | 23.77M | 21.11M | 11.96M | 23.15M | 9.8M | 11.07M | 9.1M | -7.83M | 11.81M | 11.77M | 11.78M | 11.29M | 20.7M | 10.4M | 16.4M |
| Current Ratio | 7.70x | 6.38x | 5.45x | 6.16x | 3.58x | 5.77x | 5.60x | 7.58x | 5.45x | 6.74x | 7.50x | 5.01x | 3.68x | 3.19x | 3.14x | 3.30x | 2.87x | 2.33x | 2.18x | 2.06x | 1.94x | 2.41x | 2.58x | 1.48x | 1.30x | 1.59x | 1.36x | 2.17x | 2.39x | 2.25x |
| Quick Ratio | 5.87x | 5.42x | 4.30x | 4.60x | 2.16x | 3.35x | 3.60x | 5.28x | 3.88x | 4.26x | 5.65x | 3.57x | 2.47x | 2.05x | 2.31x | 2.28x | 2.07x | 1.39x | 1.44x | 1.24x | 1.05x | 1.53x | 1.73x | 0.60x | 0.50x | 0.61x | 0.51x | 1.24x | 1.37x | 1.07x |
| Cash Conversion Cycle | 78.65 | 52.79 | 63.51 | 59.5 | 91 | 85.13 | 67.46 | 61.9 | 62.66 | 85.95 | 49.48 | 55.02 | 56.53 | 57.66 | 45.39 | 54.97 | 46.3 | 46.38 | 43.38 | 49.35 | 49.55 | 43.77 | 23.95 | 52.66 | 54.03 | 50.65 | 44.42 | 53.13 | 38.72 | 60.5 |
| Total Non-Current Liabilities | 282.73M | 228.1M | 174.15M | 171.41M | 148.29M | 139.22M | 113.1M | 91.56M | 86.93M | 123.92M | 110.95M | 122.55M | 95.81M | 97.39M | 106.33M | 114.48M | 136.35M | 146.15M | 121.15M | 131.18M | 131.55M | 95.31M | 102.4M | 111.88M | 117.2M | 120.11M | 118.7M | 91.7M | 83M | 71.5M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 641K | 2.55M | 6.11M | 9.25M | 40.8M | 50.88M | 54.65M | 64.76M | 76.42M | 104.7M | 115.98M | 95.28M | 109.28M | 92.01M | 72.84M | 80.43M | 95.65M | 108M | 111.16M | 112.63M | 79.9M | 71M | 59.9M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 747K | 1.47M | 2.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 243.07M | 172.52M | 157.04M | 161.41M | 138.01M | 127.33M | 102.03M | 82.6M | 76.06M | 110.28M | 95.38M | 76M | 40.5M | 38.42M | 38.41M | 34.72M | 28.36M | 26.64M | 21.76M | 19.75M | 18.93M | 20.29M | 20.07M | 14.74M | 7.75M | 7.5M | 4.58M | 10.3M | 10.3M | 10M |
| Other Non-Current Liabilities | 39.65M | 55.58M | 17.11M | 10M | 9.53M | 10.42M | 8.68M | 8.33M | 8.32M | 7.53M | 6.32M | 5.75M | 4.44M | 4.32M | 3.17M | 3.35M | 3.3M | 3.53M | 4.12M | 2.15M | 20.61M | 2.17M | 1.9M | 1.48M | 1.45M | 1.45M | 1.49M | 1.5M | 1.7M | 1.6M |
| Total Liabilities | 488.24M | 536.47M | 401.89M | 354.14M | 332.96M | 229.31M | 206.29M | 166.47M | 194.76M | 188.6M | 194.4M | 224.09M | 216.92M | 227.58M | 246.99M | 221.97M | 254.33M | 249.84M | 223.87M | 206.94M | 196.42M | 147.68M | 161.39M | 169.31M | 175.19M | 168.56M | 170.55M | 133.1M | 123.7M | 107.7M |
| Total Debt | 0 | 0 | 0 | 0 | 1.44M | 2.38M | 3.39M | 2.34M | 6.09M | 10.94M | 25.57M | 50.86M | 61.09M | 65.02M | 76.22M | 88.16M | 134.67M | 138.19M | 117.11M | 128.15M | 103.91M | 82.99M | 90.03M | 108.24M | 125.36M | 118.34M | 127.24M | 84M | 75.5M | 64.4M |
| Net Debt | -113.52M | -500.39M | -237.88M | -292.82M | -57.64M | -54.97M | -74.74M | -66.91M | -42.34M | -6.63M | -3.48M | 42.19M | 46.57M | 40.04M | -20.91M | 30.48M | 35.22M | 71.31M | 22.25M | 113.12M | 90.62M | 62.77M | 53.4M | 102.15M | 120.48M | 105.21M | 120.69M | 47.8M | 34.4M | 40.7M |
| Debt / Equity | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.03x | 0.07x | 0.10x | 0.13x | 0.16x | 0.21x | 0.36x | 0.41x | 0.42x | 0.81x | 0.86x | 0.68x | 0.64x | 1.64x | 2.30x | 1.79x | 2.07x | 1.04x | 0.95x | 0.86x |
| Debt / EBITDA | - | - | - | - | 0.01x | 0.07x | 0.06x | 0.02x | 0.04x | - | 0.05x | 0.18x | 0.33x | 0.69x | 0.64x | 0.77x | 1.00x | 0.91x | 0.47x | 1.61x | 4.14x | 20.16x | 0.73x | 2.52x | 13.36x | 3.46x | - | 3.85x | 3.37x | 1.70x |
| Net Debt / EBITDA | -0.24x | -0.31x | -0.61x | -0.28x | -0.27x | -1.66x | -1.26x | -0.67x | -0.27x | - | -0.01x | 0.15x | 0.25x | 0.43x | -0.18x | 0.27x | 0.26x | 0.47x | 0.09x | 1.42x | 3.61x | 15.25x | 0.43x | 2.38x | 12.84x | 3.08x | - | 2.19x | 1.54x | 1.07x |
| Interest Coverage | 617.54x | 2620.51x | 656.68x | 1713.78x | 412.95x | -45.71x | 41.28x | 110.95x | 443.78x | -358.42x | 422.50x | 107.59x | 44.10x | 17.84x | 28.56x | 14.37x | 14.59x | 18.10x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 2.64B | 2.57B | 1.8B | 1.61B | 1.1B | 1.01B | 1.01B | 989.81M | 955.68M | 844.49M | 917.36M | 704.56M | 594.75M | 518.04M | 479.33M | 418.88M | 376.96M | 333.01M | 277.37M | 157.63M | 120.69M | 121.86M | 140.16M | 66.08M | 54.46M | 66.2M | 61.35M | 80.6M | 79.5M | 74.6M |
| Equity Growth % | 2.9% | 42.79% | 11.65% | 45.75% | 9.04% | 0.31% | 2.01% | 3.57% | 13.17% | -7.94% | 30.2% | 18.46% | 14.81% | 8.08% | 14.43% | 11.12% | 13.2% | 20.06% | 75.96% | 30.61% | -0.95% | -13.06% | 112.1% | 21.35% | -17.73% | 7.89% | -23.88% | 1.38% | 6.57% | 55.74% |
| Book Value per Share | 55.26 | 52.48 | 36.77 | 32.96 | 22.66 | 20.82 | 20.83 | 20.37 | 19.72 | 17.46 | 18.97 | 14.55 | 12.31 | 10.77 | 10.01 | 8.75 | 7.89 | 6.99 | 5.84 | 3.34 | 2.57 | 2.56 | 2.88 | 1.39 | 1.16 | 1.37 | 1.26 | 1.61 | 1.51 | 0.85 |
| Total Shareholders' Equity | 2.63B | 2.56B | 1.8B | 1.61B | 1.1B | 1.01B | 1.01B | 986.62M | 953.33M | 842.69M | 915.27M | 703.56M | 593.83M | 517.73M | 479.13M | 418.91M | 377.93M | 332.05M | 275.68M | 155.74M | 119.78M | 121.86M | 140.16M | 66.08M | 54.46M | 66.2M | 61.35M | 80.6M | 79.5M | 74.6M |
| Common Stock | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 751K | 375K | 375K | 375K | 375K | 375K | 375K | 375K | 375K | 375K | 375K | 375K | 188K | 188K | 188K | 188K | 200K | 200K | 0 |
| Retained Earnings | 2.77B | 2.57B | 1.76B | 1.57B | 1.07B | 975.98M | 975.15M | 954.53M | 924.92M | 816.05M | 890.44M | 679.97M | 572.87M | 498.71M | 466.16M | 406.36M | 365.82M | 320.62M | 267.62M | 147.67M | 112.18M | 114.37M | 125.91M | 60.21M | 48.59M | 59.75M | 53.53M | 71.5M | 67M | 61.9M |
| Treasury Stock | -217.77M | -85.89M | -31.6M | -30.01M | -28.45M | -27.43M | -26.67M | -25.87M | -24.97M | -23.91M | -22.27M | -20.48M | -20.45M | -20.57M | -20.84M | -20.93M | -20.97M | -21.05M | -21.16M | -21.35M | -21.48M | -21.51M | -12.43M | -13.1M | -13.1M | -12.53M | -11.15M | -9.9M | 0 | 0 |
| Accumulated OCI | -1.47M | -1.01M | -1.77M | -2.89M | -1.6M | -558K | 79K | 355K | -693K | -128K | -48K | 22K | 561K | 166K | -222K | -320K | 0 | 0 | -852K | 0 | 0 | 0 | 0 | 0 | -116.5M | -103.6M | -89M | -74.4M | -70M | -65.8M |
| Minority Interest | 7.8M | 5.39M | -3.1M | -1.5M | -206K | 0 | 0 | 3.18M | 2.35M | 1.81M | 2.09M | 998K | 912K | 312K | 203K | -29K | -973K | 958K | 1.69M | 1.89M | 919K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CALM stock.
As of 2026, Cal-Maine Foods, Inc. (CALM) had total assets of $3.13B including $1.58B in current assets.
Cal-Maine Foods, Inc. (CALM) carries total debt of $0.0M, offset by $930.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Cal-Maine Foods, Inc. (CALM) has total shareholders' equity (book value) of $2.63B ($55.26 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Cal-Maine Foods, Inc. (CALM) reported a current ratio of 7.70x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Egg price normalization
Metrics are mathematically derived from official filings.
Balance Sheet Expands Amid Cyclical Downturn
Total assets grew from $2.1B to $3.1B over ten quarters, while equity rose to $2.6B, as per reported figures, indicating continued reinvestment despite revenue normalization.
The balance sheet has strengthened in absolute terms, with total assets up roughly 48% from 2024Q3 to 2026Q4, driven largely by retained earnings and increased PPE. This expansion suggests management is using the cyclical windfall to build long-term capacity, particularly in cage-free facilities, even as current profitability contracts. The trajectory implies a strategic focus on positioning for future regulatory and market shifts rather than maximizing short-term returns.
Debt-Free Capital Structure Provides Flexibility
Cal-Maine carries zero total debt across all reported quarters, with a current ratio above 6.4, as per financial statements, underscoring a fortress balance sheet that can weather industry downturns.
The absence of debt eliminates refinancing risk and interest expense, allowing the company to allocate cash flow to capex and dividends. This conservative leverage is consistent with management's historical approach and provides a significant competitive advantage, especially if smaller peers face liquidity constraints during HPAI-related disruptions. The D/E ratio is effectively zero, which may indicate untapped borrowing capacity for future acquisitions.
Asset Base Shifts Toward Productive Capacity
PP&E net increased from $826.6M to $1.3B over ten quarters, while goodwill rose to $97.1M, as reported, reflecting investments in cage-free conversion and acquisitions.
The growth in PP&E, up over 57% from 2024Q3 to 2026Q4, signals a deliberate expansion of production capacity, likely to meet cage-free mandates. Goodwill, though still modest relative to total assets, has more than doubled from $45.8M to $97.1M, suggesting recent acquisitions at premium valuations. Investors should monitor whether these assets generate adequate returns as egg prices normalize, given the elevated capital intensity.
Retained Earnings Bolster Equity Quality
Retained earnings climbed from $1.7B to $2.8B over the period, as per reported figures, while equity reached $2.6B, indicating strong internal capital generation despite recent losses.
The substantial increase in retained earnings, up 65% from 2024Q3 to 2026Q4, reflects the cumulative profitability from the HPAI-driven peak, which has been reinvested rather than fully distributed. This enhances equity quality, as the book value is backed by tangible assets and cash, not just intangibles. However, the variable dividend policy means shareholders may see reduced payouts in the current downturn, which could pressure the stock's income appeal.
Liquidity Buffer Remains Robust
Cash fell from $500.4M in 2025Q4 to $113.5M in 2026Q4, yet the current ratio stands at 7.7, as per financial statements, indicating ample short-term coverage.
The sharp decline in cash, down 77% from the peak, is likely due to capex, dividends, and working capital needs as revenue normalized. Despite this, the current ratio of 7.7 remains exceptionally high, providing a substantial buffer against operational shocks. The liquidity position suggests the company can fund ongoing cage-free conversions and potential acquisitions without external financing, even if egg prices remain depressed.
Biological Asset Valuation May Distort Trends
The balance sheet does not separately disclose flock values, but PPE growth and depreciation patterns, as per reported figures, may obscure the true cost of maintaining production capacity.
The company's biological assets (hens) are likely embedded within PP&E or current assets, and their depreciation and replacement cycle can mask underlying cash flow trends. As the industry transitions to cage-free, accelerated depreciation on older facilities may weigh on reported earnings while the company is actually improving its competitive position. Investors should scrutinize the cash flow statement for flock replacement costs, which are not explicitly broken out, to assess the sustainability of current margins.